Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 17, 2017
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
Fri, July 14, 2017
[ Fri, Jul 14th 2017
] - WOPRAI
[ Fri, Jul 14th 2017
] - WOPRAI
[ Fri, Jul 14th 2017
] - WOPRAI
[ Fri, Jul 14th 2017
] - WOPRAI
Ken Trbovich Initiated (SUPN) at Hold and Held Target at $47 on, Jul 14th, 2017
Ken Trbovich of Janney Montgomery Scott, Initiated "Supernus Pharmaceuticals, Inc." (SUPN) at Hold and Held Target at $47 on, Jul 14th, 2017.
Ken has made no other calls on SUPN in the last 4 months.
There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with Ken's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ken
- David Amsellem of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $44 on, Thursday, June 1st, 2017
Similar Stocks and Investing Articles
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Wed, Jul 01st 2015
] - WOPRAI
[ Mon, Apr 21st 2014
] - WOPRAI
[ Tue, Nov 19th 2013
] - WOPRAI
[ Tue, May 14th 2013
] - WOPRAI
[ Mon, Apr 22nd 2013
] - WOPRAI
[ Fri, Mar 15th 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI